以往的研究表明,局部或全身的微量营养素代谢紊乱都可能加速年龄相关性白内障的发生和发展。近年来对锌、硒、镁等微量元素在白内障发生发展中作用的研究有了新的进展,同时还发现许多有机营养素如肌肽、茶多酚和原花青素等,它们对晶状体的保护能力比传统的抗氧化剂要强得多。因此,结合先进的制药技术,研制一种能显著延缓年龄相关性白内障发生发展的药物将会有重大的意义。 Previous studies have shown that local or systemic micronutrient metabolism disorders may accelerate the occurrence and development of age-related cataracts. In recent years, new progress has been made in the research on the role of trace elements such as zinc, selenium and magnesium in the development of cataract. At the same time, many organic nutrients such as carnosine, polyphenols and proanthocyanidins have also been found, which protect the lens more than traditional Antioxidants are much stronger. Therefore, combining advanced pharmaceutical technology, it will be of great significance to develop a drug that can significantly delay the development of age-related cataracts.